Balancing Act: Weighing the Pros and Cons of Genetic Testing in Rare DiseasesSeptember 30, 2024Rare DiseasesGene Therapy
Time Warp: Fax Machines Still Common in Oncology Practice. Why?July 3, 2024Gene TherapyMixed TopicsNeuro-oncologyPediatricsBusiness of Medicine
Doctors Endorsing Products on X May Not Disclose Company TiesJune 19, 2024Gene TherapyMixed TopicsNeuro-oncologyBusiness of Medicine
Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Gene TherapyNeuro-oncologyPediatricsMixed TopicsBusiness of Medicine
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Mixed TopicsNeuro-oncologyGene TherapyPediatrics
Despite Few CNS Gene Therapies for Epilepsy, New Research Offers HopeJanuary 5, 2024Epilepsy & SeizuresGene Therapy
Genetic therapies bring change to neurology clinicsNovember 6, 2023Neuromuscular DisordersGene Therapy
Why genetic testing may be our best shot at progress in Parkinson’s diseaseJuly 28, 2023Parkinson's DiseaseMovement DisordersGene Therapy
Survey identifies clinicians’ unease with genetic testingSeptember 21, 2021Parkinson's DiseaseGene TherapyMovement Disorders
FDA approves Zolgensma for infantile-onset SMA treatmentMay 24, 2019Rare DiseasesPediatricsGene Therapy
New brain circuitry found with Parkinson’s disease gene therapyNovember 28, 2018Movement DisordersParkinson's DiseaseGene Therapy
